AGA can provide GI experts for commentary on scientific, patient care and health policy issues. Please email us at


Media Contacts

Aimee Frank
AGA senior director of communications

Rachel Shubert
AGA director, public relations



New Drugs for Inflammatory Bowel Disease (IBD)

Jan. 19, 2018

Based on the research being presented at the Crohn's & Colitis Congress™, we are hopeful that future IBD patients will have new and effective treatment options.

AGA Journals' embargo policy

When a manuscript is accepted for publication in Gastroenterology, Clinical Gastroenterology and Hepatology, or Cellular and Molecular Gastroenterology and Hepatology it is under embargo until it is available online in the “Article in Press” section of the respective journal.

This policy was updated on Sept. 16, 2015.